Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients
Background: The aim of this study was to identify predictors of insufficient beta-lactam concentrations in patients undergoing extracorporeal membrane oxygenation (ECMO). Methods: Retrospective analysis of all patients receiving ECMO support and treated with ceftazidime or cefepime (CEF), piperacill...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4f2ef32e759b42aaa8fc534a1755e74d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4f2ef32e759b42aaa8fc534a1755e74d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4f2ef32e759b42aaa8fc534a1755e74d2021-11-25T18:24:20ZPrediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients10.3390/microorganisms91122192076-2607https://doaj.org/article/4f2ef32e759b42aaa8fc534a1755e74d2021-10-01T00:00:00Zhttps://www.mdpi.com/2076-2607/9/11/2219https://doaj.org/toc/2076-2607Background: The aim of this study was to identify predictors of insufficient beta-lactam concentrations in patients undergoing extracorporeal membrane oxygenation (ECMO). Methods: Retrospective analysis of all patients receiving ECMO support and treated with ceftazidime or cefepime (CEF), piperacillin/tazobactam (TZP), or meropenem (MEM). Trough drug concentrations (C<sub>min</sub>) were measured before the subsequent dose, according to the decision of the attending physician. Insufficient drug concentrations were identified if C<sub>min</sub> was below the clinical breakpoint of Pseudomonas aeruginosa. Results: A total of 222 C<sub>min</sub> (CEF, n = 41; TZP, n = 85; MEM, n = 96) from 110 patients were included; insufficient concentrations were observed in 26 (12%) antibiotic assessments; 21 (81%) of those occurred during MEM therapy. Insufficient C<sub>min</sub> were associated with a shorter time from initiation of antibiotics to measurement, a lower single dose of antibiotic, a higher creatinine clearance (CrCL), lower sequential organ failure assessment (SOFA) scores, and less use of continuous renal replacement therapy (CRRT) when compared to others. Conclusions: Insufficient broad-spectrum beta-lactam concentrations were observed in 12% of drug measurement during ECMO therapy. Higher than recommended drug regimens could be considered in the very early phase of therapy and in those patients with augmented renal clearance and with less severe organ dysfunction.Amandine PolainJulie GorhamImmacolata RomeoMirko BelliatoLorenzo PelusoFrancesco PartipiloHassane NjimiAlexandre BrasseurFrederique JacobsJacques CreteurMaya HitesFabio Silvio TacconeMDPI AGarticleECMOantibioticstherapeutic drug monitoringcritical illnessBiology (General)QH301-705.5ENMicroorganisms, Vol 9, Iss 2219, p 2219 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
ECMO antibiotics therapeutic drug monitoring critical illness Biology (General) QH301-705.5 |
spellingShingle |
ECMO antibiotics therapeutic drug monitoring critical illness Biology (General) QH301-705.5 Amandine Polain Julie Gorham Immacolata Romeo Mirko Belliato Lorenzo Peluso Francesco Partipilo Hassane Njimi Alexandre Brasseur Frederique Jacobs Jacques Creteur Maya Hites Fabio Silvio Taccone Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients |
description |
Background: The aim of this study was to identify predictors of insufficient beta-lactam concentrations in patients undergoing extracorporeal membrane oxygenation (ECMO). Methods: Retrospective analysis of all patients receiving ECMO support and treated with ceftazidime or cefepime (CEF), piperacillin/tazobactam (TZP), or meropenem (MEM). Trough drug concentrations (C<sub>min</sub>) were measured before the subsequent dose, according to the decision of the attending physician. Insufficient drug concentrations were identified if C<sub>min</sub> was below the clinical breakpoint of Pseudomonas aeruginosa. Results: A total of 222 C<sub>min</sub> (CEF, n = 41; TZP, n = 85; MEM, n = 96) from 110 patients were included; insufficient concentrations were observed in 26 (12%) antibiotic assessments; 21 (81%) of those occurred during MEM therapy. Insufficient C<sub>min</sub> were associated with a shorter time from initiation of antibiotics to measurement, a lower single dose of antibiotic, a higher creatinine clearance (CrCL), lower sequential organ failure assessment (SOFA) scores, and less use of continuous renal replacement therapy (CRRT) when compared to others. Conclusions: Insufficient broad-spectrum beta-lactam concentrations were observed in 12% of drug measurement during ECMO therapy. Higher than recommended drug regimens could be considered in the very early phase of therapy and in those patients with augmented renal clearance and with less severe organ dysfunction. |
format |
article |
author |
Amandine Polain Julie Gorham Immacolata Romeo Mirko Belliato Lorenzo Peluso Francesco Partipilo Hassane Njimi Alexandre Brasseur Frederique Jacobs Jacques Creteur Maya Hites Fabio Silvio Taccone |
author_facet |
Amandine Polain Julie Gorham Immacolata Romeo Mirko Belliato Lorenzo Peluso Francesco Partipilo Hassane Njimi Alexandre Brasseur Frederique Jacobs Jacques Creteur Maya Hites Fabio Silvio Taccone |
author_sort |
Amandine Polain |
title |
Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients |
title_short |
Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients |
title_full |
Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients |
title_fullStr |
Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients |
title_full_unstemmed |
Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients |
title_sort |
prediction of insufficient beta-lactam concentrations in extracorporeal membranous oxygenation patients |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/4f2ef32e759b42aaa8fc534a1755e74d |
work_keys_str_mv |
AT amandinepolain predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT juliegorham predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT immacolataromeo predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT mirkobelliato predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT lorenzopeluso predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT francescopartipilo predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT hassanenjimi predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT alexandrebrasseur predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT frederiquejacobs predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT jacquescreteur predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT mayahites predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients AT fabiosilviotaccone predictionofinsufficientbetalactamconcentrationsinextracorporealmembranousoxygenationpatients |
_version_ |
1718411193882771456 |